In this small cohort ( n = 24), higher TNM stage and lymph node metastasis, two well‐known risk factors for ESCC, were associated with increased hazard of disease relapse and death with a borderline significance (Figure S14A ), indicating the robustness of the prognostic data.
← all excerpts
A multi-omics study delineates new molecular features and therapeutic targets for esophageal squamous cell carcinoma.
1
—
—